Concepedia

Ben Jenkins

BJ

Statistics

Publications

6

Citations

474

H-Index

6

Active since

2003

Affiliations

Institute of Cancer Research(Current)

Beatson West of Scotland Cancer Centre

Velindre NHS Trust

Royal Marsden Hospital

Royal Marsden NHS Foundation Trust

Ben Jenkins is an author at Institute of Cancer Research specializing in oncology, medicine, and neoadjuvant therapy monitoring.

ORCID

Publications per year

2003–2022

6

Publications

6

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Annals of Oncology · 2022 · 191 citations · Full text

, , +17

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Prerna Mehta, Ben Jenkins, Lauren McCarthy et al. · Oncogene · 2003 · 182 citations

, , +14

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Dionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 56 citations · Full text

, , +17

Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).

Alison Birtle, John Chester, Robert J. Jones et al. · Journal of Clinical Oncology · 2021 · 21 citations

, , +17

Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Cancer Research · 2022 · 14 citations

, , +17

1–5 of 6